Profile
AYTU ZTS HLN TAK TEVA VTRS
Company Name Aytu BioPharma, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $9.16M $79.26B $43.23B $42.13B $18.71B $15.67B
Employees 0.10K 14.10K 25.41K 49.28K 37.00K 32.00K
CEO Mr. Joshua R. Disbrow Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Scott Andrew Smith Ph.D.
Ratings
AYTU ZTS HLN TAK TEVA VTRS
Quant Rating Score 4 3 3 3 1 3
Quant Rating Buy Neutral Neutral Neutral Strong Sell Neutral
Trading
AYTU ZTS HLN TAK TEVA VTRS
Last Close $1.49 $175.67 $9.48 $13.29 $17.03 $13.13
High 52 $3.36 $199.94 $10.69 $15.08 $18.96 $13.53
Low 52 $1.49 $145.54 $8.01 $12.6 $10.44 $10.05
Price vs. 52 Week High -55.65 % -12.14 % -11.32 % -11.87 % -10.18 % -2.96 %
Price vs. 52 Week Low 0 % 20.7 % 18.35 % 5.48 % 63.12 % 30.65 %
Total Return
AYTU ZTS HLN TAK TEVA VTRS
1 Month Return -33.18 % -7.27 % -5.01 % -6.08 % -6.33 % 13.48 %
3 Month Return -44.61 % -3.95 % -3.95 % -11.04 % -6.07 % 12.03 %
6 Month Return -52.4 % 1.67 % 11.27 % 0.68 % 2.65 % 19.8 %
9 Month Return -50.5 % -6.75 % 13.81 % -9.84 % 31 % -0.98 %
YTD Return -47.54 % -10.99 % 15.19 % -6.87 % 63.12 % 21.24 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AYTU ZTS HLN TAK TEVA VTRS
Dividend Yield Percentage (TTM) - 0.98 % 2.08 % 4.77 % - 3.66 %
Dividend Paid and Capex Coverage Ration (TTM) -17.4 % 2.1 % - 1.29 % 5.06 % 2.39 %
Dividend Per Share (TTM) - 1.73 % 0.16 % 0.63 % - 0.48 %
Payout Ratio (TTM) - 31.44 % - 101.62 % - -65.15 %
Growth
AYTU ZTS HLN TAK TEVA VTRS
Asset Growth -13.46 % -4.28 % -2.18 % 8.25 % -1.2 % -4.67 %
Gross Profit Growth -18.08 % 3.7 % 5.85 % -16.6 % 9.64 % -0.9 %
Revenue Growth -24.58 % 5.74 % 4.09 % 5.87 % 6.16 % -5.14 %
Revenue 3 Year -81.29 % 31.98 % 13.9 % 33.13 % -6.92 % -35.32 %
Revenue 5 Year -92.22 % 53.64 % 32.87 % 149.89 % -23.33 % -41.73 %
Revenue 10 Year -99.78 % 103.1 % 32.87 % 154.38 % -40.82 % -26.57 %
EBIT Growth 69.21 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Net Income Growth 7.1 % 10.88 % -1.04 % -54.56 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 95.88 % 47.55 % -8.67 % -61.74 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share 99.76 % 71.94 % 59.66 % 62.27 % 76.28 % -93.3 %
Net Income 10 Yeari Growth Per Share 100 % 404.24 % 59.66 % 36.33 % -133.42 % -97.12 %
Operating Income Growth 69.21 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Operating Cash Flow Growth (CFG) 72.94 % 23.06 % -16.48 % -34.47 % -13.96 % -5.18 %
Operating 3 Year CFG 99.19 % 14.12 % 22.08 % -36.76 % 10.09 % 13.84 %
Operating 5 Year CFG 99.93 % 37.69 % 118.54 % 139.61 % -48.98 % -48.37 %
Operating 10 Year CFG 100 % 274.61 % 118.54 % 335.67 % -67.94 % -16.8 %
EPS Growth 44.03 % 12.64 % - -54.92 % 76.42 % -97.08 %
EPS Diluted Growth 44.03 % 12.92 % - -54.86 % 76.42 % -97.08 %
Book Value Per Share -57.54 % 15.25 % 1.35 % 13.54 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share -96.95 % 36.7 % -36.6 % 40.38 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share -97.25 % 139.55 % -39.41 % 73.27 % -53.44 % -27.35 %
Share Holder 10 Year Equity Growth Per Share -100 % 476.36 % -39.41 % 197.1 % -74.76 % 128.81 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -0.06 %
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 146.94 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 103.93 % -100 % -
Debt Growth -7.53 % -15.91 % -9.43 % 24.67 % -6.53 % -5.93 %
Free Cash Flow Growth 72.94 % 22.25 % -20.06 % -53.54 % -19.19 % -7.35 %
Updated On 30 Jun 2024 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
AYTU ZTS HLN TAK TEVA VTRS
Gross Profit Margin TTM 68.61 % 68.87 % 59.91 % 62.47 % 49.87 % 40.26 %
Return on Assets TTM -5.4 % 16.93 % 3.26 % 1.99 % -2.38 % -1.97 %
Return on Equity TTM -20.64 % 47.99 % 6.54 % 4.04 % -14.58 % -4.43 %
Return on Capital Employed TTM -8.57 % 26.64 % 7.25 % 5.27 % 7.66 % -0.71 %
Net Income Per EBT TTM 140.26 % 79.65 % 65.38 % 109.03 % 175.89 % 92.81 %
EBT Per Ebit TTM 95.26 % 90.51 % 82.66 % 41.38 % -26.34 % 359.67 %
EBIT Per Revenue TTM -6.2 % 36.83 % 17.88 % 14.14 % 12.76 % -1.76 %
Cash Flow To Debt Ratio TTM -19.26 % 44.8 % - 17.01 % 13 % 13.05 %
Receivables Turnover TTM 3.26 6.49 5.27 6.3 4.85 3.81
Payables Turnover TTM 1.75 7.05 1.25 4.13 3.55 7.23
Inventory Turnover TTM 2.02 1.18 3.09 1.41 2.13 2.2
Fixed Asset Turnover TTM 3937.25 % 259.93 % 604.62 % 240.84 % 278.05 % 561.67 %
Asset Turnover TTM 65.16 % 63.75 % 33.71 % 31.2 % 40.19 % 33.6 %
Operating Cash Flow Per Share TTM -0.32 6.5 - 545.34 2.18 1.93
Free Cash Flow Per Share TTM -0.34 5.1 - 309.43 1.75 1.6
Cash Per Share TTM 272.83 % 378.45 % 5.72 % 57513.46 % 292.94 % 157.41 %
Operating Cash Flow Sales Ratio TTM -3.14 % 32.18 % - 18.9 % 14.71 % 15.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.75 % 78.37 % - 56.74 % 80.23 % 83.19 %
Cash Flow Coverage Ratios TTM -19.26 % 44.8 % - 17.01 % 13 % 13.05 %
Price To Free Cash Flows Ratio TTM -3.66 34.34 - 13.34 9.45 8.19
Price To Operating Cash Flows Ratio TTM -4.64 27.02 - 3.76 7.82 6.81
Price Cash Flow Ratio TTM -4.64 27.02 - 3.76 7.82 6.81
Income Statement (TTM)
AYTU ZTS HLN TAK TEVA VTRS
Revenue $0.08B $8.54B $11.3B $4263.76B $15.85B $15.43B
Gross Profit $0.05B $5.83B $6.96B $2321.31B $7.65B $6.44B
Gross Profit Ratio 67.39% 68.28% 61.6% 54.44% 48.25% 41.74%
EBITDA $-0B $3.69B $2.35B $900.33B $4.33B $3.52B
Net Income $-0.02B $2.34B $1.05B $144.07B $-0.56B $0.05B
EPS Diluted -2.86 5.07 0.11 91.16 -0.5 0.05
Balance Sheet (MRQ)
AYTU ZTS HLN TAK TEVA VTRS
Long Term Debt $0.01B $6.75B $8.95B $5029.93B $18.48B $16.35B
Total Liabilities $0.09B $9.3B $17.33B $7834.79B $35.35B $27.22B
Total Equity $0.03B $4.99B $16.73B $7274.01B $8.13B $20.47B
Total Investments $-0B $0.02B $0.07B $683.22B $0.01B $1.33B
Total Debt $0.02B $6.76B $9.46B $5463.39B $20.15B $18.37B
Total Assets $0.12B $14.29B $34.06B $15108.79B $43.48B $47.69B
Cash Flow Statement (TTM)
AYTU ZTS HLN TAK TEVA VTRS
Net Income $-0.02B $2.34B $1.05B $144.07B $-0.62B $0.05B
Inventory $0B $-0.36B $-0.13B $-115.74B $0B $-0.61B
Dividends Paid $0B $-0.69B $-0.39B $-287.19B $0B $-0.58B
Operating Cash Flow $-0B $2.35B $1.72B $640.32B $1.37B $2.8B
Capital Expenditure $0B $-0.73B $-0.34B $-480.73B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.32
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.33
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.33
ALVOW Alvotech 3.49
AMPH Amphastar Pharmaceuticals, Inc. 44.58
AMRX Amneal Pharmaceuticals, Inc. 8.33
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 56.315
AQST Aquestive Therapeutics, Inc. 4.585
ASRT Assertio Holdings, Inc. 0.9467
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 11.5
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to AYTU
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 131.23
VXF Vanguard Extended Market Index Fund 0 200.81
PQSV PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF 0.1 66.2468
DFAT Dimensional U.S. Targeted Value ETF 0.00004432 59.31
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000058 35.8433
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.17
DFSU Dimensional US Sustainability Core 1 ETF 0.0004382 38.8516
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.17
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 368.12
Unlock